Skip to main navigation Skip to search Skip to main content

Genome-wide association meta-analysis of functional outcome after ischemic stroke

  • Martin Söderholm
  • , Annie Pedersen
  • , Erik Lorentzen
  • , Tara M. Stanne
  • , Steve Bevan
  • , Maja Olsson
  • , John W. Cole
  • , Israel Fernandez-Cadenas
  • , Graeme J. Hankey
  • , Jordi Jimenez-Conde
  • , Katarina Jood
  • , Jin Moo Lee
  • , Robin Lemmens
  • , Christopher Levi
  • , Braxton D. Mitchell
  • , Bo Norrving
  • , Kristiina Rannikmäe
  • , Natalia S. Rost
  • , Jonathan Rosand
  • , Peter M. Rothwell
  • Rodney Scott, Daniel Strbian, Jonathan W. Sturm, Cathie Sudlow, Matthew Traylor, Vincent Thijs, Turgut Tatlisumak, Daniel Woo, Bradford B. Worrall, Jane M. Maguire, Arne Lindgren, Christina Jern
  • Lund University
  • Institute of Biomedicine
  • University of Gothenburg
  • Sahlgrenska University Hospital
  • University of Maryland, Baltimore
  • Hospital de la Sant Pau
  • Autonomous University of Barcelona
  • University of Western Australia
  • Hospital del Mar
  • Washington University St. Louis
  • KU Leuven
  • Flanders Institute for Biotechnology
  • School of Medicine and Public Health
  • Hunter Medical Research Institute, Australia
  • University of Newcastle
  • Department of Veterans Affairs
  • University of Edinburgh
  • Massachusetts General Hospital
  • The Broad Institute of MIT and Harvard
  • University of Virginia
  • University of Oxford
  • Helsinki University Hospital
  • University of Cambridge
  • University of Melbourne
  • University of Cincinnati
  • University of Technology Sydney
  • PRC Stroke and Brain Injury
  • University of Lincoln

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Abstract

ObjectiveTo discover common genetic variants associated with poststroke outcomes using a genome-wide association (GWA) study.MethodsThe study comprised 6,165 patients with ischemic stroke from 12 studies in Europe, the United States, and Australia included in the GISCOME (Genetics of Ischaemic Stroke Functional Outcome) network. The primary outcome was modified Rankin Scale score after 60 to 190 days, evaluated as 2 dichotomous variables (0-2 vs 3-6 and 0-1 vs 2-6) and subsequently as an ordinal variable. GWA analyses were performed in each study independently and results were meta-analyzed. Analyses were adjusted for age, sex, stroke severity (baseline NIH Stroke Scale score), and ancestry. The significance level was p < 5 × 10-8.ResultsWe identified one genetic variant associated with functional outcome with genome-wide significance (modified Rankin Scale scores 0-2 vs 3-6, p = 5.3 × 10-9). This intronic variant (rs1842681) in the LOC105372028 gene is a previously reported trans-Expression quantitative trait locus for PPP1R21, which encodes a regulatory subunit of protein phosphatase 1. This ubiquitous phosphatase is implicated in brain functions such as brain plasticity. Several variants detected in this study demonstrated suggestive association with outcome (p < 10-5), some of which are within or near genes with experimental evidence of influence on ischemic stroke volume and/or brain recovery (e.g., NTN4, TEK, and PTCH1).ConclusionsIn this large GWA study on functional outcome after ischemic stroke, we report one significant variant and several variants with suggestive association to outcome 3 months after stroke onset with plausible mechanistic links to poststroke recovery. Future replication studies and exploration of potential functional mechanisms for identified genetic variants are warranted.

Original languageEnglish
Pages (from-to)E1271-E1283
JournalNeurology
Volume92
Issue number12
DOIs
StatePublished - Mar 19 2019

Fingerprint

Dive into the research topics of 'Genome-wide association meta-analysis of functional outcome after ischemic stroke'. Together they form a unique fingerprint.

Cite this